Natixis Dexcom Inc Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Dexcom Inc stock. As of the latest transaction made, Natixis holds 157,864 shares of DXCM stock, worth $12.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

157,864

Previous 89,791 75.81%

Holding current value

$12.7 Million

Previous $10.2 Million 3.93%

% of portfolio

0.06%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$64.0 - $116.06 $4.36 Million - $7.9 Million	68,073 Added 75.81%	157,864 $10.6 Million
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $9.02 Million - $11.5 Million	81,791 Added 1022.39%	89,791 $10.2 Million
Q1 2024 May 13, 2024	BUY	$114.22 - $140.1 $182,752 - $224,160	1,600 Added 25.0%	8,000 $1.11 Million
Q4 2023 Feb 13, 2024	BUY	$75.49 - $124.16 $483,135 - $794,624	6,400 New	6,400 $794,000
Q4 2022 Feb 24, 2023	SELL	$84.98 - $122.67 $2.35 Million - $3.39 Million	-27,654 Reduced 31.71%	59,549 $6.74 Million
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $2.4 Million - $3.46 Million	28,224 Added 47.85%	87,203 $9.87 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.62 Million - $2 Million	-21,223 Reduced 26.46%	58,979 $4.81 Million
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $4.7 Million - $9.18 Million	-69,058 Reduced 46.27%	80,202 $5.99 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $3.43 Million - $4.75 Million	-36,449 Reduced 19.63%	149,260 $76.4 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $6.8 Million - $8.53 Million	52,360 Added 39.27%	185,709 $99.7 Million
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $6.09 Million - $8.17 Million	57,052 Added 74.78%	133,349 $72.9 Million
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $3.16 Million - $4.21 Million	38,964 Added 104.37%	76,297 $32.6 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $3.01 Million - $3.71 Million	-35,441 Reduced 48.7%	37,333 $13.4 Million
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $5.68 Million - $7.6 Million	72,774 New	72,774 $26.9 Million
Q2 2020 Aug 13, 2020	SELL	$62.68 - $105.34 $2.75 Million - $4.63 Million	-43,923 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$47.79 - $75.63 $1.63 Million - $2.57 Million	34,030 Added 343.98%	43,923 $11.8 Million
Q4 2019 Feb 14, 2020	BUY	$36.62 - $57.29 $362,281 - $566,769	9,893 New	9,893 $2.14 Million
Q4 2018 Feb 14, 2019	SELL	$26.99 - $37.37 $198,268 - $274,520	-7,346 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $171,529 - $269,745	7,346 New	7,346 $1.05 Million
Q3 2017 Nov 14, 2017	SELL	$11.36 - $18.98 $117,962 - $197,088	-10,384 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	10,384	10,384 $760,000

Others Institutions Holding DXCM

# of Institutions

1,014

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account